A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas. // International Journal of Radiation Oncology, Biology, Physics. – URL: https://www.sciencedirect.com/science/article/pii/S0360301626042318?dgcid=rss_sd_all
A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas. International Journal of Radiation Oncology, Biology, Physics. https://www.sciencedirect.com/science/article/pii/S0360301626042318?dgcid=rss_sd_all
“A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas.” International Journal of Radiation Oncology, Biology, Physics.
@article{article50047,
title = {A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas},
journal = {International Journal of Radiation Oncology, Biology, Physics},
url = {https://www.sciencedirect.com/science/article/pii/S0360301626042318?dgcid=rss_sd_all}
}